chr2-166199711-G-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001365536.1(SCN9A):c.4928C>A(p.Ala1643Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1643T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.4928C>A | p.Ala1643Glu | missense_variant | 27/27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.4928C>A | p.Ala1643Glu | missense_variant | 27/27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.4928C>A | p.Ala1643Glu | missense_variant | 27/27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.4895C>A | p.Ala1632Glu | missense_variant | 27/27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.4895C>A | p.Ala1632Glu | missense_variant | 27/27 | ENSP00000495983.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Paroxysmal extreme pain disorder Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Feb 13, 2017 | - - |
Pathogenic, no assertion criteria provided | research | Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences | Nov 16, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 25, 2015 | The A1632E missense variant in the SCN9A gene has been reported previously as a de novo variant in a patient with characteristics of both inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD) (Estacion et al., 2008). Functional analysis shows that A1632E alters channel function and results in neuronal hyperexciability (Estacion et al., 2008). The A1632E variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. It is a non-conservative amino acid substitution that occurs at a highly conserved position in between the S4 and S5 transmembrane segments of the forth homologous domain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at